Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG
- 1 December 1988
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 15 (6) , 1337-1346
- https://doi.org/10.1016/0360-3016(88)90229-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Levamisole as an adjuvant to chemotherapy in extensive bronchogenic carcinoma. A veterans administration lung cancer group studyCancer, 1982
- Adjuvant immunotherapy by levamisole in resectable lung cancer: A control studyPublished by Elsevier ,1980
- Adjuvant treatment with levamisole in cancer a review of experimental and clinical dataCancer Treatment Reviews, 1977
- COMPLICATIONS OF CANCER IMMUNOTHERAPY WITH LEVAMISOLEThe Lancet, 1977
- Irradiation for bronchial carcinoma: Reasons for failure.I. Analysis of local control as a function of dose, time, and fractionationCancer, 1976
- LEVAMISOLE IN ADVANCED HUMAN BREAST CANCERThe Lancet, 1976
- Immunopotentiation with levamisole in resectable bronchogenic carcinoma: a double-blind controlled trial; Study Group for Bronchogenic Carcinoma.BMJ, 1975
- THYMUS-DEPENDENT LYMPHOCYTE LEVELS DURING RADIATION THERAPY FOR BRONCHOGENIC AND ESOPHAGEAL CARCINOMA: CORRELATIONS WITH CLINICAL COURSE IN RESPONDERS AND NONRESPONDERSAmerican Journal of Roentgenology, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Some Methods for Strengthening the Common χ 2 TestsPublished by JSTOR ,1954